CLYM

Climb Bio

19 hedge funds and large institutions have $48.4M invested in Climb Bio in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

21% less capital invested

Capital invested by funds: $61M → $48.4M (-$12.6M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$353K
2 +$223K
3 +$180K
4
AI
Atom Investors
Texas
+$9.38K
5
TRCT
Tower Research Capital (TRC)
New York
+$7.23K

Top Sellers

1 -$484K
2 -$92.6K
3 -$2.61K
4
Northern Trust
Northern Trust
Illinois
-$716
5
Millennium Management
Millennium Management
New York
-$186
Name Holding Trade Value Shares
Change
Change in
Stake
1
$38.1M
2
$4.81M
3
$1.95M
4
$1.41M
5
$796K
6
$229K
7
$196K
8
$186K
9
$181K
10
$160K
11
$94.8K
12
$86K
13
$57.4K
14
$52.4K
15
$43.1K
16
$32.6K
17
$9K
18
$2.02K
19
$122
20